Literature DB >> 8717156

Altered in vivo catecholamine release in the hypothalamic paraventricular nucleus of the aged rat.

J A Hastings1, J M Pavia, M J Morris.   

Abstract

The effect of age on basal and stimulated noradrenaline release in the hypothalamic paraventricular nucleus (PVN) of the rat was examined by in vivo microdialysis. Microdialysis probes were inserted into the PVN of 3 and 18 month old anaesthetised Sprague Dawley rats and perfused with a modified Ringer solution. Following four basal 30-min collections, transmitter release was stimulated by perfusion with 100 mM potassium for one collection. After re-equilibration, blood pressure was raised 60 mmHg for 30 min by phenylephrine infusion (1-1.3 mg/kg) then a 2-h recovery period followed. Dialysate collections were injected directly onto a reverse phase HPLC-ECD (HPLC with electrochemical detection). Basal extracellular noradrenaline concentrations were found to be similar in adult and old animals. Basal dihydroxyphenylacetic acid (DOPAC) concentrations were significantly greater in old compared to adult rats (P < 0.05). Potassium depolarisation induced a significant increase in noradrenaline concentrations in both age groups (P < 0.001), however the noradrenaline response to potassium stimulation was significantly reduced in the aged rats (P < 0.05). Potassium-induced decreases in DOPAC and homovanillic acid (HVA) concentrations were seen in both age groups. Following phenylephrine infusion, a modest delayed reduction in noradrenaline levels, which failed to reach statistical significance, was seen. Phenylephrine-induced hypertension was associated with decreased DOPAC and HVA concentrations in adult (P < 0.05) and old (P < 0.05) rats, respectively. These results indicate that ageing is associated with changes in dopaminergic and noradrenergic activity in the PVN of the rat. A reduction in noradrenaline response to maximal stimulation induced by potassium depolarisation was observed with ageing. The alteration in the activity of the catecholaminergic pathways to the PVN induced by phenylephrine infusion appears to be age dependent.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8717156     DOI: 10.1007/BF00168753

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  43 in total

1.  Age-related central and baroreceptor impairment in female Sprague-Dawley rats.

Authors:  S Tanabe; R D Buñag
Journal:  Am J Physiol       Date:  1989-05

Review 2.  Presynaptic alpha-autoreceptors.

Authors:  K Starke
Journal:  Rev Physiol Biochem Pharmacol       Date:  1987       Impact factor: 5.545

3.  Regional changes in monoamine metabolism in the aging constant estrous rat.

Authors:  J W Simpkins
Journal:  Neurobiol Aging       Date:  1984       Impact factor: 4.673

4.  Changes in catecholamine levels in discrete regions of rat brain during aging.

Authors:  I F Roubein; L J Embree; D W Jackson
Journal:  Exp Aging Res       Date:  1986       Impact factor: 1.645

Review 5.  Ageing of the neuropeptidergic signals in rats.

Authors:  S P Kalra; A Sahu; P S Kalra
Journal:  J Reprod Fertil Suppl       Date:  1993

6.  Active transport pumps of HVA and DOPAC in dopaminergic nerve terminals.

Authors:  J K Miyamoto; E Uezu; S Terashima
Journal:  Physiol Behav       Date:  1991-01

7.  Comparison of norepinephrine release in hypertensive rats: I. Hypothalamic and brainstem tissues.

Authors:  M J Meldrum; T C Westfall
Journal:  Clin Exp Hypertens A       Date:  1986

8.  Catecholamine release in the rat hypothalamic paraventricular nucleus in response to haemorrhage, desipramine and potassium.

Authors:  M J Morris; J A Hastings; J M Pavia
Journal:  Brain Res       Date:  1994-11-28       Impact factor: 3.252

9.  Age effects on monoamine turnover of the rat substantia nigra.

Authors:  J L Venero; A Machado; J Cano
Journal:  Brain Res       Date:  1991-08-23       Impact factor: 3.252

10.  Characteristics of dopaminergic neurons in the aged male rat.

Authors:  K T Demarest; G D Riegle; K E Moore
Journal:  Neuroendocrinology       Date:  1980-09       Impact factor: 4.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.